April 2019

Biofluid Biomarkers Hold Promise for the Future of Huntington Disease

April 29, 2019

Features

Currently, there are no disease-modifying medications for Huntington disease and few interventions available to effectively alleviate symptoms, while the lack of indicators of pathobiological processes at the molecular level has limited the ability to prove efficacy and safety in clinical trials.

Creativity, Persistence Are Key to Advancing the Approach to MS Symptom Management

April 27, 2019

Features

Although highly efficacious DMTs have improved outcomes for a growing number of patients, the majority of people with MS are still subjected to the day-to-day consequences of the disease’s symptoms, which often have a more debilitating effect on the patient than the disease itself.

Disease Management on the Horizon in Alzheimer Disease

April 25, 2019

Features

NeurologyLive spoke with the director of the Cleveland Clinic Lou Ruvo Center for Brain Health to learn why, despite hundreds of failed trials and therapies, there is growing excitement for what's to come.